CooperVision Inc said delayed annual meeting June 22 May 14 allow board review possible recapitalization option meeting .
CooperVision today reported first quarter net income 64.6 mln dlrs , 175.2 mln dlr pretax gain sale ophthalmic business Johnson Johnson & lt ; JNJ > 260 mln dlrs cash 17.9 mln dlr posttax charge debt repurchase .
Sales 94.4 mln dlrs .
A year earlier earned 7,300,000 dlrs 120,000 dlr loss discontinued operation , sale 85.4 mln dlrs .
The company said aggressive program investment spending maintain increase market share two core business accelerate sale growth year hold back increase operating income near future .
CooperVision said `` Furthermore , entire net cash proceeds recent sale several business employed reduce indebtedness , make strategic acquisition and/or otherwise employed relation possible recapitalization company , recovery net income held back loss , particularly tax income , ( ophthalmic ) pharmaceutical business sold Johnson Johnson .
'' Reuter & # 3 ; 